Stevens–Johnson syndrome and toxic epidermal necrolysis overlap in a patient receiving cetuximab and radiotherapy for head and neck cancer

Authors


  • Conflicts of interest: None.

Mirjana Urosevic-Maiwald, md
Assistant Professor
Department of Dermatology
University Hospital Zurich
Gloriastrasse 31
8091 Zurich
Switzerland
E-mail: mirjana.urosevic@usz.ch

Abstract

Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe and life-threatening adverse drug reactions. Herein we report about a patient with head and neck cancer, who developed SJS-TEN overlap after having received cetuximab and radiotherapy. To date, there are only two reports of TEN associated with cetuximab therapy in patients with cancer. Every skin condition in a patient with cancer leading to extensive exfoliation of the skin should alert the oncologist of a possibility of drug-induced SJS or TEN.

Ancillary